Hengrui Medicine (600276.SS) — market event timeline

nashnova tracks 1 market event mentioning Hengrui Medicine (600276.SS) as of 2026-07-31, each with a dated one-line analysis of how the event relates to the asset.

  1. China's 12th National Drug Bulk Procurement Round Successfully Purchases 65 Drugs

    The largest A-share prescription drug company, with multiple anti-tumor and other products facing bulk procurement price cuts, affecting revenue expectations for its generics segment.

For research and information only — not investment advice.

Hengrui Medicine (600276.SS) — News & AI Analysis · nashnova